The market may open lower Thursday due to Trump's 25% tariff on Indian goods and penalties for trade with Russia.

Pharmaceutical stocks came under pressure on Thursday, July 31, after US President Donald Trump announced a sweeping 25% ...

Nifty Pharma index declined 1.5 per cent in trade after US President Donald Trump warned to impose a 25 per cent tariff on ...

The group acknowledges limited growth in South Africa’s price-regulated pharma market but believes Natco’s backing will ...

A recent history of NIFTY MIDCAP performance shows a volatile performance. It had alternating gains and losses in the past 4 ...

The Nifty Pharma index ended Friday on a positive note, advancing 0.54%. Top gainers included Cipla Ltd and Torrent Pharmaceuticals Ltd, while Natco Pharma Ltd led the losses.

Natco Pharma’s R4-billion proposal to take a stake of almost 36% in Adcock Ingram was a vote of confidence in the JSE-listed ...

The U.S. FDA had inspected the API facility, in Mekaguda here, from June 9-13 and issued Form 483 with one observation. The regulator had classified it as “voluntary action indicated” (VAI), the ...

On Thursday, 1644 stocks advanced, 2409 declined and 168 remained unchanged on Bombay Stock Exchange with advance decline ...

Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about $232 million (R4 billion).

Hyderabad: NATCO Pharma Limited has announced that the U.S. Food and Drug Administration (USFDA) has issued an Establishment ...

Stock market today opened with mixed signals as investors reacted to global cues and Q1 earnings from major companies. The ...